Tuesday, September 07, 2010
Search:
All
Cases
Slides
News
Factoids
Authors
My
Account
Username:
Password:
Register
Forgot Username/Password
Coronary
Endovascular
Structural
Pharmacology
Imaging
DES
CTO
VP
News
Slides
Cases
CME
Multimedia
Events
supporters:
Breaking News
Breaking news and information will be placed here.
TCTMD Spotlight
advertisement
Getting latest news...
Featured Content
Slides
3-Year Interim Results of the Percutaneous MONARC™ System for the Treatment of Functional Mitral Regurgitation
Jan Harnek
Interim Results: Comparison of Prasugrel vs. High Clopidogrel Maintenance Dose to Overcome High Residual Platelet Reactivity Post Stenting
I. Xanthopoulou
MULTI STRATEGY: 3-year Follow-up
Marco Valgimigli
view all slides
Cases
FFR-guided PCI of Protected Ostial Left Main: Demonstration of Flow Inadequacy Via LIMA
Rajesh Sachdeva
Carotid Stenting in an Octogenarian with Subtotal Occlusion (String Sign)
Hussien Heshmat
Treatment of Superior Vena Cava Syndrome Caused by SVC CTO
Magdi Ghali
view all cases
submit a case
CME Programs
Antiplatelet Therapy in the Catheterization Laboratory
Active until October 15, 2011
Improved Clinical Synergy: Combination Antiplatelet Therapy and DES
Active until October 15, 2010
Controversies in Ischemic Heart Disease
Active until November 16, 2010
view all CME programs
TCTMD Poll
What area would be most important to receive hands-on training?
Vascular access and closure devices
IVC filter deployment and re-capturing
Trans-septal crossing techniques
Cardiac imaging guidance for structural heart disease
News from Industry
Tuesday, August 31, 2010
Bayer's Rivaroxaban Successfully Meets Primary Efficacy Outcome and Demonstrates Similar Safety to Standard Therapy in Phase III EINSTEIN-DVT Non-Inferiority Study
Monday, August 30, 2010
InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
Monday, August 30, 2010
Philips Introduces Newly Enhanced Cardiac Ultrasound System
Monday, August 30, 2010
Medtronic Launches Resolute Integrity Drug-Eluting Stent In Europe
Sunday, August 29, 2010
Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients
view all news from industry
Events
view all events
Centers of Excellence
Coronary
Structural
Supported by Edwards Lifesciences
Chronic Total Occlusions
Supported by Abbott Vascular
Drug Eluting Stents
Endovascular
Pharmacology
Imaging
Vulnerable Plaque
Featured Video
view all videos »
advertisement
10.2.19.1